世界の全身性特発性若年性関節炎治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5537
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、96ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療

• 販売価格（消費税別）

Single User	￥546,000 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥819,000 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,092,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、全身性特発性若年性関節炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）、用途別市場規模（クリニック、病院、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・全身性特発性若年性関節炎治療の市場動向
・企業の競争状況、市場シェア
・全身性特発性若年性関節炎治療の種類別市場規模（アダリムマブバイオシミラー、カナキヌマブ、ゴリムマブ、トシリズマブバイオシミラー、その他）
・全身性特発性若年性関節炎治療の用途別市場規模（クリニック、病院、その他）
・全身性特発性若年性関節炎治療の北米市場規模2016-2027（アメリカ、カナダ）
・全身性特発性若年性関節炎治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・全身性特発性若年性関節炎治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・全身性特発性若年性関節炎治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・全身性特発性若年性関節炎治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Alteogen Inc.、Bristol-Myers Squibb Company、Epirus Biopharmaceuticals, Inc.、Johnson & Johnson、Momenta Pharmaceuticals, Inc.、Mycenax Biotech Inc.、Novartis AG、Oncobiologics, Inc.）
・結論

Market Analysis and Insights: Global Systemic Idiopathic Juvenile Arthritis Treatment Market
The global Systemic Idiopathic Juvenile Arthritis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Systemic Idiopathic Juvenile Arthritis Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Systemic Idiopathic Juvenile Arthritis Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Systemic Idiopathic Juvenile Arthritis Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Systemic Idiopathic Juvenile Arthritis Treatment market.

Global Systemic Idiopathic Juvenile Arthritis Treatment Scope and Market Size
Systemic Idiopathic Juvenile Arthritis Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Systemic Idiopathic Juvenile Arthritis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Adalimumab Biosimilar
Canakinumab
Golimumab
Tocilizumab Biosimilar
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Alteogen Inc.
Bristol-Myers Squibb Company
Epirus Biopharmaceuticals, Inc.
Johnson & Johnson
Momenta Pharmaceuticals, Inc.
Mycenax Biotech Inc.
Novartis AG
Oncobiologics, Inc.

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Adalimumab Biosimilar
1.2.3 Canakinumab
1.2.4 Golimumab
1.2.5 Tocilizumab Biosimilar
1.2.6 Others
1.3 Market by Application
1.3.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Perspective (2016-2027)
2.2 Systemic Idiopathic Juvenile Arthritis Treatment Growth Trends by Regions
2.2.1 Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Systemic Idiopathic Juvenile Arthritis Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Systemic Idiopathic Juvenile Arthritis Treatment Industry Dynamic
2.3.1 Systemic Idiopathic Juvenile Arthritis Treatment Market Trends
2.3.2 Systemic Idiopathic Juvenile Arthritis Treatment Market Drivers
2.3.3 Systemic Idiopathic Juvenile Arthritis Treatment Market Challenges
2.3.4 Systemic Idiopathic Juvenile Arthritis Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Systemic Idiopathic Juvenile Arthritis Treatment Players by Revenue
3.1.1 Global Top Systemic Idiopathic Juvenile Arthritis Treatment Players by Revenue (2016-2021)
3.1.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Systemic Idiopathic Juvenile Arthritis Treatment Revenue
3.4 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Concentration Ratio
3.4.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Systemic Idiopathic Juvenile Arthritis Treatment Revenue in 2020
3.5 Systemic Idiopathic Juvenile Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Systemic Idiopathic Juvenile Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Systemic Idiopathic Juvenile Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Systemic Idiopathic Juvenile Arthritis Treatment Breakdown Data by Type
4.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Historic Market Size by Type (2016-2021)
4.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Type (2022-2027)

5 Systemic Idiopathic Juvenile Arthritis Treatment Breakdown Data by Application
5.1 Global Systemic Idiopathic Juvenile Arthritis Treatment Historic Market Size by Application (2016-2021)
5.2 Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2016-2027)
6.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
6.2.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021)
6.2.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027)
6.2.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2027)
6.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
6.3.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021)
6.3.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027)
6.3.3 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2027)
6.4 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
6.4.1 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021)
6.4.2 North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2016-2027)
7.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
7.2.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021)
7.2.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027)
7.2.3 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2027)
7.3 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
7.3.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021)
7.3.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027)
7.3.3 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2027)
7.4 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
7.4.1 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021)
7.4.2 Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2016-2027)
8.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
8.2.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
8.3.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region
8.4.1 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2016-2027)
9.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
9.2.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2027)
9.3 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
9.3.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2027)
9.4 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
9.4.1 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size (2016-2027)
10.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type
10.2.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application
10.3.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country
10.4.1 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Alteogen Inc.
11.1.1 Alteogen Inc. Company Details
11.1.2 Alteogen Inc. Business Overview
11.1.3 Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.1.4 Alteogen Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.1.5 Alteogen Inc. Recent Development
11.2 Bristol-Myers Squibb Company
11.2.1 Bristol-Myers Squibb Company Company Details
11.2.2 Bristol-Myers Squibb Company Business Overview
11.2.3 Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.2.4 Bristol-Myers Squibb Company Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.2.5 Bristol-Myers Squibb Company Recent Development
11.3 Epirus Biopharmaceuticals, Inc.
11.3.1 Epirus Biopharmaceuticals, Inc. Company Details
11.3.2 Epirus Biopharmaceuticals, Inc. Business Overview
11.3.3 Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.3.4 Epirus Biopharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.3.5 Epirus Biopharmaceuticals, Inc. Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.4.4 Johnson & Johnson Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.4.5 Johnson & Johnson Recent Development
11.5 Momenta Pharmaceuticals, Inc.
11.5.1 Momenta Pharmaceuticals, Inc. Company Details
11.5.2 Momenta Pharmaceuticals, Inc. Business Overview
11.5.3 Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.5.4 Momenta Pharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.5.5 Momenta Pharmaceuticals, Inc. Recent Development
11.6 Mycenax Biotech Inc.
11.6.1 Mycenax Biotech Inc. Company Details
11.6.2 Mycenax Biotech Inc. Business Overview
11.6.3 Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.6.4 Mycenax Biotech Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.6.5 Mycenax Biotech Inc. Recent Development
11.7 Novartis AG
11.7.1 Novartis AG Company Details
11.7.2 Novartis AG Business Overview
11.7.3 Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.7.4 Novartis AG Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.7.5 Novartis AG Recent Development
11.8 Oncobiologics, Inc.
11.8.1 Oncobiologics, Inc. Company Details
11.8.2 Oncobiologics, Inc. Business Overview
11.8.3 Oncobiologics, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Introduction
11.8.4 Oncobiologics, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
11.8.5 Oncobiologics, Inc. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Adalimumab Biosimilar
Table 3. Key Players of Canakinumab
Table 4. Key Players of Golimumab
Table 5. Key Players of Tocilizumab Biosimilar
Table 6. Key Players of Others
Table 7. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Regions (2016-2021)
Table 11. Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Regions (2022-2027)
Table 13. Systemic Idiopathic Juvenile Arthritis Treatment Market Trends
Table 14. Systemic Idiopathic Juvenile Arthritis Treatment Market Drivers
Table 15. Systemic Idiopathic Juvenile Arthritis Treatment Market Challenges
Table 16. Systemic Idiopathic Juvenile Arthritis Treatment Market Restraints
Table 17. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Players (2016-2021)
Table 19. Global Top Systemic Idiopathic Juvenile Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Idiopathic Juvenile Arthritis Treatment as of 2020)
Table 20. Ranking of Global Top Systemic Idiopathic Juvenile Arthritis Treatment Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Systemic Idiopathic Juvenile Arthritis Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Systemic Idiopathic Juvenile Arthritis Treatment Product Solution and Service
Table 24. Date of Enter into Systemic Idiopathic Juvenile Arthritis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Type (2016-2021)
Table 28. Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Application (2016-2021)
Table 32. Global Systemic Idiopathic Juvenile Arthritis Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 64. Alteogen Inc. Company Details
Table 65. Alteogen Inc. Business Overview
Table 66. Alteogen Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 67. Alteogen Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 68. Alteogen Inc. Recent Development
Table 69. Bristol-Myers Squibb Company Company Details
Table 70. Bristol-Myers Squibb Company Business Overview
Table 71. Bristol-Myers Squibb Company Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 72. Bristol-Myers Squibb Company Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 73. Bristol-Myers Squibb Company Recent Development
Table 74. Epirus Biopharmaceuticals, Inc. Company Details
Table 75. Epirus Biopharmaceuticals, Inc. Business Overview
Table 76. Epirus Biopharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 77. Epirus Biopharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 78. Epirus Biopharmaceuticals, Inc. Recent Development
Table 79. Johnson & Johnson Company Details
Table 80. Johnson & Johnson Business Overview
Table 81. Johnson & Johnson Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 82. Johnson & Johnson Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 83. Johnson & Johnson Recent Development
Table 84. Momenta Pharmaceuticals, Inc. Company Details
Table 85. Momenta Pharmaceuticals, Inc. Business Overview
Table 86. Momenta Pharmaceuticals, Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 87. Momenta Pharmaceuticals, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 88. Momenta Pharmaceuticals, Inc. Recent Development
Table 89. Mycenax Biotech Inc. Company Details
Table 90. Mycenax Biotech Inc. Business Overview
Table 91. Mycenax Biotech Inc. Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 92. Mycenax Biotech Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 93. Mycenax Biotech Inc. Recent Development
Table 94. Novartis AG Company Details
Table 95. Novartis AG Business Overview
Table 96. Novartis AG Systemic Idiopathic Juvenile Arthritis Treatment Product
Table 97. Novartis AG Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 98. Novartis AG Recent Development
Table 99. Oncobiologics, Inc. Company Details
Table 100. Oncobiologics, Inc. Business Overview
Table 101. Oncobiologics, Inc. Revenue in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021) & (US$ Million)
Table 102. Oncobiologics, Inc. Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type: 2020 VS 2027
Figure 2. Adalimumab Biosimilar Features
Figure 3. Canakinumab Features
Figure 4. Golimumab Features
Figure 5. Tocilizumab Biosimilar Features
Figure 6. Others Features
Figure 7. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application: 2020 VS 2027
Figure 8. Clinic Case Studies
Figure 9. Hospital Case Studies
Figure 10. Others Case Studies
Figure 11. Systemic Idiopathic Juvenile Arthritis Treatment Report Years Considered
Figure 12. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Regions: 2020 VS 2027
Figure 15. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Regions (2022-2027)
Figure 16. Global Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Players in 2020
Figure 17. Global Top Systemic Idiopathic Juvenile Arthritis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Systemic Idiopathic Juvenile Arthritis Treatment as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Systemic Idiopathic Juvenile Arthritis Treatment Revenue in 2020
Figure 19. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Type (2016-2021)
Figure 20. Global Systemic Idiopathic Juvenile Arthritis Treatment Revenue Market Share by Type (2022-2027)
Figure 21. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2016-2027)
Figure 23. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2016-2027)
Figure 24. North America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Country (2016-2027)
Figure 25. United States Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2016-2027)
Figure 29. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2016-2027)
Figure 30. Europe Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Country (2016-2027)
Figure 31. Germany Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Region (2016-2027)
Figure 41. China Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2016-2027)
Figure 49. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2016-2027)
Figure 50. Latin America Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Country (2016-2027)
Figure 51. Mexico Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Systemic Idiopathic Juvenile Arthritis Treatment Market Share by Country (2016-2027)
Figure 57. Turkey Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Systemic Idiopathic Juvenile Arthritis Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Alteogen Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 61. Bristol-Myers Squibb Company Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 62. Epirus Biopharmaceuticals, Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 63. Johnson & Johnson Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 64. Momenta Pharmaceuticals, Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 65. Mycenax Biotech Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 66. Novartis AG Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 67. Oncobiologics, Inc. Revenue Growth Rate in Systemic Idiopathic Juvenile Arthritis Treatment Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed

以下、関連資料のご紹介

世界の若年性特発性関節炎治療市場規模・現状・予測（2021年-2027年）

Global Juvenile Idiopathic Arthritis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3305 2021年4月 99Pages
QYResearch社発行の本調査資料では、若年性特発性関節炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（外科的治療、薬物治療）、用途別市場規模（病院、クリニック、診断研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日...

世界の若年性黄斑変性症治療市場規模・現状・予測（2021年-2027年）

Global Juvenile Macular Degeneration Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3307 2021年4月 94Pages
QYResearch社発行の本調査資料では、若年性黄斑変性症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アバシンカプタドペゴルナトリウム、エコーチオフェートヨウ化物、エミクススタト塩酸塩、FAB-111、その他）、用途別市場規模（クリニ...

世界の若年性黄斑変性症治療市場規模・現状・予測（2021年-2027年）

世界の全身感染症治療市場規模・現状・予測（2021年-2027年）

Global Systemic Infection Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5539 2021年4月 99Pages
QYResearch社発行の本調査資料では、全身感染症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（抗菌、抗ウイルス、防カビ）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国...

世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年）

Global Rheumatoid Arthritis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z5047 2021年4月 90Pages
QYResearch社発行の本調査資料では、関節リウマチ治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（対症療法、中間副腎皮質ステロイド療法、疾患緩和抗リウマチ薬療法）、用途別市場規模（病院薬局、小売薬局、ドラッグストア）、主要地域別市場規...

世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年）

世界の犬関節炎治療市場規模・現状・予測（2021年-2027年）

Global Canine Arthritis Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z1080 2021年4月 95Pages
QYResearch社発行の本調査資料では、犬関節炎治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非ステロイド性抗炎症薬、オピオイド）、用途別市場規模（獣医病院・クリニック、ドラッグストア、Eコマース）、主要地域別市場規模（北米、アメリカ...

世界の犬関節炎治療市場規模・現状・予測（2021年-2027年）

世界の特発性頭蓋内圧亢進症治療市場規模・現状・予測（2021年-2027年）

Global Idiopathic Intracranial Hypertension Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z3017 2021年4月 127Pages
QYResearch社発行の本調査資料では、特発性頭蓋内圧亢進症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アセタゾラミド、メタゾラミド、フロセミド、トピラマート、その他）、用途別市場規模（病院、クリニック、外来手術センター）、主要地域...

世界の慢性特発性骨髄線維症市場規模・現状・予測（2021年-2027年）

Global Chronic Idiopathic Myelofibrosis Market Size, Status and Forecast 2021-2027
QYR2104Z1315 2021年4月 92Pages
QYResearch社発行の本調査資料では、慢性特発性骨髄線維症のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、生物学的療法、その他）、用途別市場規模（病院、クリニック、研究機関）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の若年性特発性関節炎治療市場規模・現状・予測（2021年-2027年） Arthritis is a very common disease but it is not well understood yet. Arthritis is basically joint pain or joint disease. Basically Juvenile idiopathic arthritis or juvenile rheumatoid arthritis is the common inflammatory arthritis of childhood and Common symptom of Juvenile idiopathic arthritis is …
世界の若年性黄斑変性症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Juvenile Macular Degeneration Treatment Market The global Juvenile Macular Degeneration Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
世界の若年性黄斑変性症治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Juvenile Macular Degeneration Treatment Market The global Juvenile Macular Degeneration Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis…
世界のアダリムマブバイオシミラー市場 2021：企業別、地域別、種類・用途別 The Adalimumab Biosimilar market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulatio…
世界の関節リウマチ治療市場規模・現状・予測（2021年-2027年） Rheumatoid arthritis is a long-term autoimmune disorder that primarily affects joints. The rheumatoid arthritis treatment market is expected to grow over the forecast period owing to the high incidence rate of rheumatoid arthritis among people. Market Analysis and Insights: Global Rheumatoid Arthrit…